Drug Shortage Report for CEFOXITIN FOR INJECTION

Last updated on 2018-01-03 History
Report ID 17868
Drug Identification Number 02240773
Brand name CEFOXITIN FOR INJECTION
Common or Proper name CEFOXITIN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CEFOXITIN
Strength(s) 10G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10G
ATC code J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-08-01
Estimated end date 2017-11-30
Actual end date 2017-12-15
Shortage status Resolved
Updated date 2018-01-03
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2018-01-03 French Compare
v6 2018-01-03 English Compare
v5 2017-10-10 French Compare
v4 2017-10-10 English Compare
v3 2017-08-02 English Compare
v2 2017-08-01 French Compare
v1 2017-08-01 English Compare